HEADER IMMUNE SYSTEM 07-FEB-23 8CH7 TITLE RDC-REFINED INTERLEUKIN-4 (WILD TYPE) PH 5.6 COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN-4; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: IL-4,B-CELL STIMULATORY FACTOR 1,BSF-1,BINETRAKIN,LYMPHOCYTE COMPND 5 STIMULATORY FACTOR 1,PITRAKINRA; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IL4; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN, SHORT-CHAIN CYTOKINE, PLEIOTROPIC, INTERLEUKIN, 4-HELIX KEYWDS 2 BUNDLE, IMMUNE SYSTEM EXPDTA SOLUTION NMR NUMMDL 2 AUTHOR D.C.VAZ,J.R.RODRIGUES,N.LOUREIRO-FERREIRA,T.MUELLER,W.SEBALD, AUTHOR 2 C.REDFIELD,R.M.M.BRITO REVDAT 2 17-JAN-24 8CH7 1 JRNL REVDAT 1 18-OCT-23 8CH7 0 JRNL AUTH D.C.VAZ,J.R.RODRIGUES,N.LOUREIRO-FERREIRA,T.D.MULLER, JRNL AUTH 2 W.SEBALD,C.REDFIELD,R.M.M.BRITO JRNL TITL LESSONS ON PROTEIN STRUCTURE FROM INTERLEUKIN-4: ALL JRNL TITL 2 DISULFIDES ARE NOT CREATED EQUAL. JRNL REF PROTEINS V. 92 219 2024 JRNL REFN ESSN 1097-0134 JRNL PMID 37814578 JRNL DOI 10.1002/PROT.26611 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH 3.6 REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8CH7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-FEB-23. REMARK 100 THE DEPOSITION ID IS D_1292128460. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 5.6 REMARK 210 IONIC STRENGTH : 10 MM REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 1.5 MM [U-13C; U-15N] REMARK 210 INTERLEUKIN-4 (IL-4), 95% H2O/5% REMARK 210 D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-13C HSQC; 2D 1H-15N HSQC; REMARK 210 2D 1H-15N HSQC IPAP; 3D 1H-15N REMARK 210 NOESY-HSQC; 3D 1H-15N TOCSY-HSQC; REMARK 210 3D 1H-13C HCCH-COSY; 3D 1H-13C REMARK 210 HCCH-TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 750 MHZ; 600 MHZ REMARK 210 SPECTROMETER MODEL : OXFORD REMARK 210 SPECTROMETER MANUFACTURER : OXFORD REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : X-PLOR NIH 3.6, FELIX REMARK 210 METHOD USED : DGSA-DISTANCE GEOMETRY SIMULATED REMARK 210 ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 2 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HD1 HIS A 1 H CYS A 3 1.16 REMARK 500 O GLN A 54 H HIS A 58 1.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 CYS A 3 -72.07 -72.60 REMARK 500 1 GLN A 20 56.39 -150.63 REMARK 500 1 THR A 22 -146.29 -138.89 REMARK 500 1 ALA A 34 27.88 -73.57 REMARK 500 1 ASN A 38 68.18 -161.92 REMARK 500 1 LYS A 61 68.58 -119.15 REMARK 500 1 ALA A 68 -158.88 -134.64 REMARK 500 1 ALA A 70 -16.49 -48.19 REMARK 500 1 LEU A 86 -71.02 -57.12 REMARK 500 1 ALA A 94 -37.61 -37.01 REMARK 500 1 LEU A 96 -136.96 -141.62 REMARK 500 1 ASN A 97 -80.85 -126.28 REMARK 500 1 ALA A 104 -46.85 -144.29 REMARK 500 1 LEU A 109 -61.74 -9.45 REMARK 500 1 LYS A 126 32.84 -73.42 REMARK 500 2 CYS A 3 -72.32 -48.10 REMARK 500 2 GLN A 20 58.77 -110.24 REMARK 500 2 THR A 22 -133.54 -152.79 REMARK 500 2 ALA A 34 21.91 -71.04 REMARK 500 2 ALA A 35 7.99 -162.82 REMARK 500 2 ASN A 38 37.21 -98.55 REMARK 500 2 ALA A 68 -158.77 -132.67 REMARK 500 2 ALA A 70 -17.79 -49.30 REMARK 500 2 LEU A 86 -71.43 -55.78 REMARK 500 2 ASN A 97 -59.92 -126.79 REMARK 500 2 ALA A 104 -46.38 -140.86 REMARK 500 2 LEU A 109 -49.60 -11.93 REMARK 500 2 SER A 128 -151.66 -151.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 34787 RELATED DB: BMRB REMARK 900 RDC-REFINED INTERLEUKIN-4 (WILD TYPE) PH 5.6 DBREF 8CH7 A 1 129 UNP P05112 IL4_HUMAN 25 153 SEQRES 1 A 129 HIS LYS CYS ASP ILE THR LEU GLN GLU ILE ILE LYS THR SEQRES 2 A 129 LEU ASN SER LEU THR GLU GLN LYS THR LEU CYS THR GLU SEQRES 3 A 129 LEU THR VAL THR ASP ILE PHE ALA ALA SER LYS ASN THR SEQRES 4 A 129 THR GLU LYS GLU THR PHE CYS ARG ALA ALA THR VAL LEU SEQRES 5 A 129 ARG GLN PHE TYR SER HIS HIS GLU LYS ASP THR ARG CYS SEQRES 6 A 129 LEU GLY ALA THR ALA GLN GLN PHE HIS ARG HIS LYS GLN SEQRES 7 A 129 LEU ILE ARG PHE LEU LYS ARG LEU ASP ARG ASN LEU TRP SEQRES 8 A 129 GLY LEU ALA GLY LEU ASN SER CYS PRO VAL LYS GLU ALA SEQRES 9 A 129 ASN GLN SER THR LEU GLU ASN PHE LEU GLU ARG LEU LYS SEQRES 10 A 129 THR ILE MET ARG GLU LYS TYR SER LYS CYS SER SER HELIX 1 AA1 ASP A 4 GLN A 20 1 17 HELIX 2 AA2 ILE A 32 THR A 39 5 8 HELIX 3 AA3 THR A 40 GLU A 60 1 21 HELIX 4 AA4 THR A 69 GLY A 95 1 27 HELIX 5 AA5 LEU A 109 SER A 125 1 17 HELIX 6 AA6 LYS A 126 SER A 128 5 3 SHEET 1 AA1 2 THR A 28 ASP A 31 0 SHEET 2 AA1 2 ASN A 105 THR A 108 -1 O SER A 107 N VAL A 29 SSBOND 1 CYS A 3 CYS A 127 1555 1555 2.02 SSBOND 2 CYS A 24 CYS A 65 1555 1555 2.02 SSBOND 3 CYS A 46 CYS A 99 1555 1555 2.02 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1